HiPSC-derived cardiomyocytes were transfected using Lipofectamin 3000 (ratio 1:2 Plasmid:Lipofectamin 3,000) (Thermo Fisher Scientific) according to the manufacturer's protocol. Four hours prior transfection the medium was changed to RPMI 1,640 (Thermo Fisher Scientific) supplemented with B-27 (#17504044, Thermo Fisher Scientific) and 10% FBS.
As negative controls only the transfection reagents and Opti-MEM were added to the cells to estimate the effects of cell toxicity due to transfection and are further indicated as non-transfected (NT).